世界のフェナゾン（アンチピリン）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Phenazone (Antipyrine) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4585 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、フェナゾン（アンチピリン）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（溶液、液体）、用途別市場規模（硝酸、亜硝酸塩、ヨウ素分析試薬、解熱剤、鎮痛剤）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・フェナゾン（アンチピリン）の市場動向 ・企業の競争状況、市場シェア ・フェナゾン（アンチピリン）の種類別市場規模（溶液、液体） ・フェナゾン（アンチピリン）の用途別市場規模（硝酸、亜硝酸塩、ヨウ素分析試薬、解熱剤、鎮痛剤） ・フェナゾン（アンチピリン）の北米市場規模2016-2027（アメリカ、カナダ） ・フェナゾン（アンチピリン）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・フェナゾン（アンチピリン）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・フェナゾン（アンチピリン）の中南米市場規模2016-2027（メキシコ、ブラジル） ・フェナゾン（アンチピリン）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Endo、Pfizer、Herbages Naturbec、Bayer、CSPC、Huadong Medicine、Northeast Pharmaceutical、NCPC、Sinopharm、Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)、Tianfang Pharmaceutical、Tianjin Jinyao Pharmaceutical、Shandong Huaxin Pharmaceutical Group、Shandong Xinhua Pharmaceutical、Shandong Fangming Pharmaceutical Group、Shanxi Taiyuan Pharmaceutical、Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.、Guangdong Sancai Shiqi District Pharmaceutical、Guangdong Nanguo Pharmaceutical、Kaifeng Pharmaceutical Group、Yuekang Pharmaceutical Group Anhui Biopharmaceutical、Xinxiang Changle Pharmaceutical、Wuhan Fuxing Biopharmaceutical、Henan Runhong Pharmaceutical、Henan Furen Huaiqingtang Pharmaceutical、Hainan Pharmaceutical Factory） ・結論

Market Analysis and Insights: Global Phenazone (Antipyrine) Market
The global Phenazone (Antipyrine) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Phenazone (Antipyrine) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Phenazone (Antipyrine) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Phenazone (Antipyrine) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Phenazone (Antipyrine) market.

Global Phenazone (Antipyrine) Scope and Market Size
Phenazone (Antipyrine) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Phenazone (Antipyrine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Solution
Liquid

Segment by Application
Analytical Reagent for Nitric Acid, Nitrite and Iodine
Antipyretic And Analgesic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Endo
Pfizer
Herbages Naturbec
Bayer
CSPC
Huadong Medicine
Northeast Pharmaceutical
NCPC
Sinopharm
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Tianfang Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shandong Huaxin Pharmaceutical Group
Shandong Xinhua Pharmaceutical
Shandong Fangming Pharmaceutical Group
Shanxi Taiyuan Pharmaceutical
Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
Guangdong Sancai Shiqi District Pharmaceutical
Guangdong Nanguo Pharmaceutical
Kaifeng Pharmaceutical Group
Yuekang Pharmaceutical Group Anhui Biopharmaceutical
Xinxiang Changle Pharmaceutical
Wuhan Fuxing Biopharmaceutical
Henan Runhong Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenazone (Antipyrine) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Solution
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Phenazone (Antipyrine) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Analytical Reagent for Nitric Acid, Nitrite and Iodine
1.3.3 Antipyretic And Analgesic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Phenazone (Antipyrine) Market Perspective (2016-2027)
2.2 Phenazone (Antipyrine) Growth Trends by Regions
2.2.1 Phenazone (Antipyrine) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Phenazone (Antipyrine) Historic Market Share by Regions (2016-2021)
2.2.3 Phenazone (Antipyrine) Forecasted Market Size by Regions (2022-2027)
2.3 Phenazone (Antipyrine) Industry Dynamic
2.3.1 Phenazone (Antipyrine) Market Trends
2.3.2 Phenazone (Antipyrine) Market Drivers
2.3.3 Phenazone (Antipyrine) Market Challenges
2.3.4 Phenazone (Antipyrine) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Phenazone (Antipyrine) Players by Revenue
3.1.1 Global Top Phenazone (Antipyrine) Players by Revenue (2016-2021)
3.1.2 Global Phenazone (Antipyrine) Revenue Market Share by Players (2016-2021)
3.2 Global Phenazone (Antipyrine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Phenazone (Antipyrine) Revenue
3.4 Global Phenazone (Antipyrine) Market Concentration Ratio
3.4.1 Global Phenazone (Antipyrine) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenazone (Antipyrine) Revenue in 2020
3.5 Phenazone (Antipyrine) Key Players Head office and Area Served
3.6 Key Players Phenazone (Antipyrine) Product Solution and Service
3.7 Date of Enter into Phenazone (Antipyrine) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Phenazone (Antipyrine) Breakdown Data by Type
4.1 Global Phenazone (Antipyrine) Historic Market Size by Type (2016-2021)
4.2 Global Phenazone (Antipyrine) Forecasted Market Size by Type (2022-2027)

5 Phenazone (Antipyrine) Breakdown Data by Application
5.1 Global Phenazone (Antipyrine) Historic Market Size by Application (2016-2021)
5.2 Global Phenazone (Antipyrine) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Phenazone (Antipyrine) Market Size (2016-2027)
6.2 North America Phenazone (Antipyrine) Market Size by Type
6.2.1 North America Phenazone (Antipyrine) Market Size by Type (2016-2021)
6.2.2 North America Phenazone (Antipyrine) Market Size by Type (2022-2027)
6.2.3 North America Phenazone (Antipyrine) Market Size by Type (2016-2027)
6.3 North America Phenazone (Antipyrine) Market Size by Application
6.3.1 North America Phenazone (Antipyrine) Market Size by Application (2016-2021)
6.3.2 North America Phenazone (Antipyrine) Market Size by Application (2022-2027)
6.3.3 North America Phenazone (Antipyrine) Market Size by Application (2016-2027)
6.4 North America Phenazone (Antipyrine) Market Size by Country
6.4.1 North America Phenazone (Antipyrine) Market Size by Country (2016-2021)
6.4.2 North America Phenazone (Antipyrine) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Phenazone (Antipyrine) Market Size (2016-2027)
7.2 Europe Phenazone (Antipyrine) Market Size by Type
7.2.1 Europe Phenazone (Antipyrine) Market Size by Type (2016-2021)
7.2.2 Europe Phenazone (Antipyrine) Market Size by Type (2022-2027)
7.2.3 Europe Phenazone (Antipyrine) Market Size by Type (2016-2027)
7.3 Europe Phenazone (Antipyrine) Market Size by Application
7.3.1 Europe Phenazone (Antipyrine) Market Size by Application (2016-2021)
7.3.2 Europe Phenazone (Antipyrine) Market Size by Application (2022-2027)
7.3.3 Europe Phenazone (Antipyrine) Market Size by Application (2016-2027)
7.4 Europe Phenazone (Antipyrine) Market Size by Country
7.4.1 Europe Phenazone (Antipyrine) Market Size by Country (2016-2021)
7.4.2 Europe Phenazone (Antipyrine) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Phenazone (Antipyrine) Market Size (2016-2027)
8.2 Asia-Pacific Phenazone (Antipyrine) Market Size by Type
8.2.1 Asia-Pacific Phenazone (Antipyrine) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Phenazone (Antipyrine) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Phenazone (Antipyrine) Market Size by Type (2016-2027)
8.3 Asia-Pacific Phenazone (Antipyrine) Market Size by Application
8.3.1 Asia-Pacific Phenazone (Antipyrine) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Phenazone (Antipyrine) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Phenazone (Antipyrine) Market Size by Application (2016-2027)
8.4 Asia-Pacific Phenazone (Antipyrine) Market Size by Region
8.4.1 Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Phenazone (Antipyrine) Market Size (2016-2027)
9.2 Latin America Phenazone (Antipyrine) Market Size by Type
9.2.1 Latin America Phenazone (Antipyrine) Market Size by Type (2016-2021)
9.2.2 Latin America Phenazone (Antipyrine) Market Size by Type (2022-2027)
9.2.3 Latin America Phenazone (Antipyrine) Market Size by Type (2016-2027)
9.3 Latin America Phenazone (Antipyrine) Market Size by Application
9.3.1 Latin America Phenazone (Antipyrine) Market Size by Application (2016-2021)
9.3.2 Latin America Phenazone (Antipyrine) Market Size by Application (2022-2027)
9.3.3 Latin America Phenazone (Antipyrine) Market Size by Application (2016-2027)
9.4 Latin America Phenazone (Antipyrine) Market Size by Country
9.4.1 Latin America Phenazone (Antipyrine) Market Size by Country (2016-2021)
9.4.2 Latin America Phenazone (Antipyrine) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Phenazone (Antipyrine) Market Size (2016-2027)
10.2 Middle East & Africa Phenazone (Antipyrine) Market Size by Type
10.2.1 Middle East & Africa Phenazone (Antipyrine) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Phenazone (Antipyrine) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Phenazone (Antipyrine) Market Size by Type (2016-2027)
10.3 Middle East & Africa Phenazone (Antipyrine) Market Size by Application
10.3.1 Middle East & Africa Phenazone (Antipyrine) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Phenazone (Antipyrine) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Phenazone (Antipyrine) Market Size by Application (2016-2027)
10.4 Middle East & Africa Phenazone (Antipyrine) Market Size by Country
10.4.1 Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Endo
11.1.1 Endo Company Details
11.1.2 Endo Business Overview
11.1.3 Endo Phenazone (Antipyrine) Introduction
11.1.4 Endo Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.1.5 Endo Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Phenazone (Antipyrine) Introduction
11.2.4 Pfizer Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Herbages Naturbec
11.3.1 Herbages Naturbec Company Details
11.3.2 Herbages Naturbec Business Overview
11.3.3 Herbages Naturbec Phenazone (Antipyrine) Introduction
11.3.4 Herbages Naturbec Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.3.5 Herbages Naturbec Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Phenazone (Antipyrine) Introduction
11.4.4 Bayer Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 CSPC
11.5.1 CSPC Company Details
11.5.2 CSPC Business Overview
11.5.3 CSPC Phenazone (Antipyrine) Introduction
11.5.4 CSPC Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.5.5 CSPC Recent Development
11.6 Huadong Medicine
11.6.1 Huadong Medicine Company Details
11.6.2 Huadong Medicine Business Overview
11.6.3 Huadong Medicine Phenazone (Antipyrine) Introduction
11.6.4 Huadong Medicine Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.6.5 Huadong Medicine Recent Development
11.7 Northeast Pharmaceutical
11.7.1 Northeast Pharmaceutical Company Details
11.7.2 Northeast Pharmaceutical Business Overview
11.7.3 Northeast Pharmaceutical Phenazone (Antipyrine) Introduction
11.7.4 Northeast Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.7.5 Northeast Pharmaceutical Recent Development
11.8 NCPC
11.8.1 NCPC Company Details
11.8.2 NCPC Business Overview
11.8.3 NCPC Phenazone (Antipyrine) Introduction
11.8.4 NCPC Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.8.5 NCPC Recent Development
11.9 Sinopharm
11.9.1 Sinopharm Company Details
11.9.2 Sinopharm Business Overview
11.9.3 Sinopharm Phenazone (Antipyrine) Introduction
11.9.4 Sinopharm Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.9.5 Sinopharm Recent Development
11.10 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.10.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
11.10.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.10.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Introduction
11.10.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.10.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
11.11 Tianfang Pharmaceutical
11.11.1 Tianfang Pharmaceutical Company Details
11.11.2 Tianfang Pharmaceutical Business Overview
11.11.3 Tianfang Pharmaceutical Phenazone (Antipyrine) Introduction
11.11.4 Tianfang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.11.5 Tianfang Pharmaceutical Recent Development
11.12 Tianjin Jinyao Pharmaceutical
11.12.1 Tianjin Jinyao Pharmaceutical Company Details
11.12.2 Tianjin Jinyao Pharmaceutical Business Overview
11.12.3 Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Introduction
11.12.4 Tianjin Jinyao Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.12.5 Tianjin Jinyao Pharmaceutical Recent Development
11.13 Shandong Huaxin Pharmaceutical Group
11.13.1 Shandong Huaxin Pharmaceutical Group Company Details
11.13.2 Shandong Huaxin Pharmaceutical Group Business Overview
11.13.3 Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Introduction
11.13.4 Shandong Huaxin Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.13.5 Shandong Huaxin Pharmaceutical Group Recent Development
11.14 Shandong Xinhua Pharmaceutical
11.14.1 Shandong Xinhua Pharmaceutical Company Details
11.14.2 Shandong Xinhua Pharmaceutical Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Introduction
11.14.4 Shandong Xinhua Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.14.5 Shandong Xinhua Pharmaceutical Recent Development
11.15 Shandong Fangming Pharmaceutical Group
11.15.1 Shandong Fangming Pharmaceutical Group Company Details
11.15.2 Shandong Fangming Pharmaceutical Group Business Overview
11.15.3 Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Introduction
11.15.4 Shandong Fangming Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.15.5 Shandong Fangming Pharmaceutical Group Recent Development
11.16 Shanxi Taiyuan Pharmaceutical
11.16.1 Shanxi Taiyuan Pharmaceutical Company Details
11.16.2 Shanxi Taiyuan Pharmaceutical Business Overview
11.16.3 Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Introduction
11.16.4 Shanxi Taiyuan Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.16.5 Shanxi Taiyuan Pharmaceutical Recent Development
11.17 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd.
11.17.1 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Company Details
11.17.2 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Business Overview
11.17.3 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Introduction
11.17.4 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.17.5 Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Recent Development
11.18 Guangdong Sancai Shiqi District Pharmaceutical
11.18.1 Guangdong Sancai Shiqi District Pharmaceutical Company Details
11.18.2 Guangdong Sancai Shiqi District Pharmaceutical Business Overview
11.18.3 Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Introduction
11.18.4 Guangdong Sancai Shiqi District Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.18.5 Guangdong Sancai Shiqi District Pharmaceutical Recent Development
11.18 Guangdong Nanguo Pharmaceutical
11.25.1 Guangdong Nanguo Pharmaceutical Company Details
11.25.2 Guangdong Nanguo Pharmaceutical Business Overview
11.25.3 Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Introduction
11.25.4 Guangdong Nanguo Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.25.5 Guangdong Nanguo Pharmaceutical Recent Development
11.20 Kaifeng Pharmaceutical Group
11.20.1 Kaifeng Pharmaceutical Group Company Details
11.20.2 Kaifeng Pharmaceutical Group Business Overview
11.20.3 Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Introduction
11.20.4 Kaifeng Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.20.5 Kaifeng Pharmaceutical Group Recent Development
11.21 Yuekang Pharmaceutical Group Anhui Biopharmaceutical
11.21.1 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Company Details
11.21.2 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Business Overview
11.21.3 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Introduction
11.21.4 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.21.5 Yuekang Pharmaceutical Group Anhui Biopharmaceutical Recent Development
11.22 Xinxiang Changle Pharmaceutical
11.22.1 Xinxiang Changle Pharmaceutical Company Details
11.22.2 Xinxiang Changle Pharmaceutical Business Overview
11.22.3 Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Introduction
11.22.4 Xinxiang Changle Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.22.5 Xinxiang Changle Pharmaceutical Recent Development
11.23 Wuhan Fuxing Biopharmaceutical
11.23.1 Wuhan Fuxing Biopharmaceutical Company Details
11.23.2 Wuhan Fuxing Biopharmaceutical Business Overview
11.23.3 Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Introduction
11.23.4 Wuhan Fuxing Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.23.5 Wuhan Fuxing Biopharmaceutical Recent Development
11.24 Henan Runhong Pharmaceutical
11.24.1 Henan Runhong Pharmaceutical Company Details
11.24.2 Henan Runhong Pharmaceutical Business Overview
11.24.3 Henan Runhong Pharmaceutical Phenazone (Antipyrine) Introduction
11.24.4 Henan Runhong Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.24.5 Henan Runhong Pharmaceutical Recent Development
11.25 Henan Furen Huaiqingtang Pharmaceutical
11.25.1 Henan Furen Huaiqingtang Pharmaceutical Company Details
11.25.2 Henan Furen Huaiqingtang Pharmaceutical Business Overview
11.25.3 Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Introduction
11.25.4 Henan Furen Huaiqingtang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.25.5 Henan Furen Huaiqingtang Pharmaceutical Recent Development
11.26 Hainan Pharmaceutical Factory
11.26.1 Hainan Pharmaceutical Factory Company Details
11.26.2 Hainan Pharmaceutical Factory Business Overview
11.26.3 Hainan Pharmaceutical Factory Phenazone (Antipyrine) Introduction
11.26.4 Hainan Pharmaceutical Factory Revenue in Phenazone (Antipyrine) Business (2016-2021)
11.26.5 Hainan Pharmaceutical Factory Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Phenazone (Antipyrine) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Solution
Table 3. Key Players of Liquid
Table 4. Global Phenazone (Antipyrine) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Phenazone (Antipyrine) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Phenazone (Antipyrine) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Phenazone (Antipyrine) Market Share by Regions (2016-2021)
Table 8. Global Phenazone (Antipyrine) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Phenazone (Antipyrine) Market Share by Regions (2022-2027)
Table 10. Phenazone (Antipyrine) Market Trends
Table 11. Phenazone (Antipyrine) Market Drivers
Table 12. Phenazone (Antipyrine) Market Challenges
Table 13. Phenazone (Antipyrine) Market Restraints
Table 14. Global Phenazone (Antipyrine) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Phenazone (Antipyrine) Market Share by Players (2016-2021)
Table 16. Global Top Phenazone (Antipyrine) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phenazone (Antipyrine) as of 2020)
Table 17. Ranking of Global Top Phenazone (Antipyrine) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Phenazone (Antipyrine) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Phenazone (Antipyrine) Product Solution and Service
Table 21. Date of Enter into Phenazone (Antipyrine) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Phenazone (Antipyrine) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Phenazone (Antipyrine) Revenue Market Share by Type (2016-2021)
Table 25. Global Phenazone (Antipyrine) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Phenazone (Antipyrine) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Phenazone (Antipyrine) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Phenazone (Antipyrine) Revenue Market Share by Application (2016-2021)
Table 29. Global Phenazone (Antipyrine) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Phenazone (Antipyrine) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Phenazone (Antipyrine) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Phenazone (Antipyrine) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Phenazone (Antipyrine) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Phenazone (Antipyrine) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Phenazone (Antipyrine) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Phenazone (Antipyrine) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Phenazone (Antipyrine) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Phenazone (Antipyrine) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Phenazone (Antipyrine) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Phenazone (Antipyrine) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Phenazone (Antipyrine) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Phenazone (Antipyrine) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Phenazone (Antipyrine) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Phenazone (Antipyrine) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Phenazone (Antipyrine) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Phenazone (Antipyrine) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Phenazone (Antipyrine) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Phenazone (Antipyrine) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Phenazone (Antipyrine) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Phenazone (Antipyrine) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Phenazone (Antipyrine) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Phenazone (Antipyrine) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Phenazone (Antipyrine) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Phenazone (Antipyrine) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Phenazone (Antipyrine) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Phenazone (Antipyrine) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Phenazone (Antipyrine) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Phenazone (Antipyrine) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Endo Company Details
Table 62. Endo Business Overview
Table 63. Endo Phenazone (Antipyrine) Product
Table 64. Endo Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 65. Endo Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Phenazone (Antipyrine) Product
Table 69. Pfizer Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Herbages Naturbec Company Details
Table 72. Herbages Naturbec Business Overview
Table 73. Herbages Naturbec Phenazone (Antipyrine) Product
Table 74. Herbages Naturbec Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 75. Herbages Naturbec Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Phenazone (Antipyrine) Product
Table 79. Bayer Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. CSPC Company Details
Table 82. CSPC Business Overview
Table 83. CSPC Phenazone (Antipyrine) Product
Table 84. CSPC Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 85. CSPC Recent Development
Table 86. Huadong Medicine Company Details
Table 87. Huadong Medicine Business Overview
Table 88. Huadong Medicine Phenazone (Antipyrine) Product
Table 89. Huadong Medicine Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 90. Huadong Medicine Recent Development
Table 91. Northeast Pharmaceutical Company Details
Table 92. Northeast Pharmaceutical Business Overview
Table 93. Northeast Pharmaceutical Phenazone (Antipyrine) Product
Table 94. Northeast Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 95. Northeast Pharmaceutical Recent Development
Table 96. NCPC Company Details
Table 97. NCPC Business Overview
Table 98. NCPC Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 99. NCPC Recent Development
Table 100. Sinopharm Company Details
Table 101. Sinopharm Business Overview
Table 102. Sinopharm Phenazone (Antipyrine) Product
Table 103. Sinopharm Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 104. Sinopharm Recent Development
Table 105. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
Table 106. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 107. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Phenazone (Antipyrine) Product
Table 108. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 109. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 110. Tianfang Pharmaceutical Company Details
Table 111. Tianfang Pharmaceutical Business Overview
Table 112. Tianfang Pharmaceutical Phenazone (Antipyrine) Product
Table 113. Tianfang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 114. Tianfang Pharmaceutical Recent Development
Table 115. Tianjin Jinyao Pharmaceutical Company Details
Table 116. Tianjin Jinyao Pharmaceutical Business Overview
Table 117. Tianjin Jinyao Pharmaceutical Phenazone (Antipyrine) Product
Table 118. Tianjin Jinyao Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 119. Tianjin Jinyao Pharmaceutical Recent Development
Table 120. Shandong Huaxin Pharmaceutical Group Company Details
Table 121. Shandong Huaxin Pharmaceutical Group Business Overview
Table 122. Shandong Huaxin Pharmaceutical Group Phenazone (Antipyrine) Product
Table 123. Shandong Huaxin Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 124. Shandong Huaxin Pharmaceutical Group Recent Development
Table 125. Shandong Xinhua Pharmaceutical Company Details
Table 126. Shandong Xinhua Pharmaceutical Business Overview
Table 127. Shandong Xinhua Pharmaceutical Phenazone (Antipyrine) Product
Table 128. Shandong Xinhua Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 129. Shandong Xinhua Pharmaceutical Recent Development
Table 130. Shandong Fangming Pharmaceutical Group Company Details
Table 131. Shandong Fangming Pharmaceutical Group Business Overview
Table 132. Shandong Fangming Pharmaceutical Group Phenazone (Antipyrine) Product
Table 133. Shandong Fangming Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 134. Shandong Fangming Pharmaceutical Group Recent Development
Table 135. Shanxi Taiyuan Pharmaceutical Company Details
Table 136. Shanxi Taiyuan Pharmaceutical Business Overview
Table 137. Shanxi Taiyuan Pharmaceutical Phenazone (Antipyrine) Product
Table 138. Shanxi Taiyuan Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 139. Shanxi Taiyuan Pharmaceutical Recent Development
Table 140. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Company Details
Table 141. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Business Overview
Table 142. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Phenazone (Antipyrine) Product
Table 143. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 144. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Recent Development
Table 145. Guangdong Sancai Shiqi District Pharmaceutical Company Details
Table 146. Guangdong Sancai Shiqi District Pharmaceutical Business Overview
Table 147. Guangdong Sancai Shiqi District Pharmaceutical Phenazone (Antipyrine) Product
Table 148. Guangdong Sancai Shiqi District Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 149. Guangdong Sancai Shiqi District Pharmaceutical Recent Development
Table 150. Guangdong Nanguo Pharmaceutical Company Details
Table 151. Guangdong Nanguo Pharmaceutical Business Overview
Table 152. Guangdong Nanguo Pharmaceutical Phenazone (Antipyrine) Product
Table 153. Guangdong Nanguo Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 154. Guangdong Nanguo Pharmaceutical Recent Development
Table 155. Kaifeng Pharmaceutical Group Company Details
Table 156. Kaifeng Pharmaceutical Group Business Overview
Table 157. Kaifeng Pharmaceutical Group Phenazone (Antipyrine) Product
Table 158. Kaifeng Pharmaceutical Group Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 159. Kaifeng Pharmaceutical Group Recent Development
Table 160. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Company Details
Table 161. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Business Overview
Table 162. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Phenazone (Antipyrine) Product
Table 163. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 164. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Recent Development
Table 165. Xinxiang Changle Pharmaceutical Company Details
Table 166. Xinxiang Changle Pharmaceutical Business Overview
Table 167. Xinxiang Changle Pharmaceutical Phenazone (Antipyrine) Product
Table 168. Xinxiang Changle Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 169. Xinxiang Changle Pharmaceutical Recent Development
Table 170. Wuhan Fuxing Biopharmaceutical Company Details
Table 171. Wuhan Fuxing Biopharmaceutical Business Overview
Table 172. Wuhan Fuxing Biopharmaceutical Phenazone (Antipyrine) Product
Table 173. Wuhan Fuxing Biopharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 174. Wuhan Fuxing Biopharmaceutical Recent Development
Table 175. Henan Runhong Pharmaceutical Company Details
Table 176. Henan Runhong Pharmaceutical Business Overview
Table 177. Henan Runhong Pharmaceutical Phenazone (Antipyrine)Product
Table 178. Henan Runhong Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 179. Henan Runhong Pharmaceutical Recent Development
Table 180. Henan Furen Huaiqingtang Pharmaceutical Company Details
Table 181. Henan Furen Huaiqingtang Pharmaceutical Business Overview
Table 182. Henan Furen Huaiqingtang Pharmaceutical Phenazone (Antipyrine) Product
Table 183. Henan Furen Huaiqingtang Pharmaceutical Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 184. Henan Furen Huaiqingtang Pharmaceutical Recent Development
Table 185. Hainan Pharmaceutical Factory Company Details
Table 186. Hainan Pharmaceutical Factory Business Overview
Table 187. Hainan Pharmaceutical Factory Phenazone (Antipyrine) Product
Table 188. Hainan Pharmaceutical Factory Revenue in Phenazone (Antipyrine) Business (2016-2021) & (US$ Million)
Table 189. Hainan Pharmaceutical Factory Recent Development
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phenazone (Antipyrine) Market Share by Type: 2020 VS 2027
Figure 2. Solution Features
Figure 3. Liquid Features
Figure 4. Global Phenazone (Antipyrine) Market Share by Application: 2020 VS 2027
Figure 5. Analytical Reagent for Nitric Acid, Nitrite and Iodine Case Studies
Figure 6. Antipyretic And Analgesic Case Studies
Figure 7. Phenazone (Antipyrine) Report Years Considered
Figure 8. Global Phenazone (Antipyrine) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Phenazone (Antipyrine) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Phenazone (Antipyrine) Market Share by Regions: 2020 VS 2027
Figure 11. Global Phenazone (Antipyrine) Market Share by Regions (2022-2027)
Figure 12. Global Phenazone (Antipyrine) Market Share by Players in 2020
Figure 13. Global Top Phenazone (Antipyrine) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phenazone (Antipyrine) as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Phenazone (Antipyrine) Revenue in 2020
Figure 15. Global Phenazone (Antipyrine) Revenue Market Share by Type (2016-2021)
Figure 16. Global Phenazone (Antipyrine) Revenue Market Share by Type (2022-2027)
Figure 17. North America Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Phenazone (Antipyrine) Market Share by Type (2016-2027)
Figure 19. North America Phenazone (Antipyrine) Market Share by Application (2016-2027)
Figure 20. North America Phenazone (Antipyrine) Market Share by Country (2016-2027)
Figure 21. United States Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Phenazone (Antipyrine) Market Share by Type (2016-2027)
Figure 25. Europe Phenazone (Antipyrine) Market Share by Application (2016-2027)
Figure 26. Europe Phenazone (Antipyrine) Market Share by Country (2016-2027)
Figure 27. Germany Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Phenazone (Antipyrine) Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Phenazone (Antipyrine) Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Phenazone (Antipyrine) Market Share by Region (2016-2027)
Figure 37. China Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Phenazone (Antipyrine) Market Share by Type (2016-2027)
Figure 45. Latin America Phenazone (Antipyrine) Market Share by Application (2016-2027)
Figure 46. Latin America Phenazone (Antipyrine) Market Share by Country (2016-2027)
Figure 47. Mexico Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Phenazone (Antipyrine) Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Phenazone (Antipyrine) Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Phenazone (Antipyrine) Market Share by Country (2016-2027)
Figure 53. Turkey Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Phenazone (Antipyrine) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Endo Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 57. Pfizer Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 58. Herbages Naturbec Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 59. Bayer Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 60. CSPC Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 61. Huadong Medicine Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 62. Northeast Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 63. NCPC Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 64. Sinopharm Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 65. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 66. Tianfang Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 67. Tianjin Jinyao Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 68. Shandong Huaxin Pharmaceutical Group Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 69. Shandong Xinhua Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 70. Shandong Fangming Pharmaceutical Group Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 71. Shanxi Taiyuan Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 72. Shanxi Jinxin Shuanghe Pharmaceutical Co. , Ltd. Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 73. Guangdong Sancai Shiqi District Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 74. Guangdong Nanguo Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 75. Kaifeng Pharmaceutical Group Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 76. Yuekang Pharmaceutical Group Anhui Biopharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 77. Xinxiang Changle Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 78. Wuhan Fuxing Biopharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 79. Henan Runhong Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 80. Henan Furen Huaiqingtang Pharmaceutical Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 81. Hainan Pharmaceutical Factory Revenue Growth Rate in Phenazone (Antipyrine) Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

---